참고문헌
- Brawley OW (2003). Hormonal prevention of prostate cancer. Urol Oncol, 21, 2167-72.
- Burke JP, Rhodes T, Jacobson DJ, et al (2006). Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol, 164, 41-6. https://doi.org/10.1093/aje/kwj151
- Center MM, Jemal A, Lortet-Tieulent J, et al (2012). International variation in prostate cancer incidence and mortality rates. Eur Urol, 61, 1079-92. https://doi.org/10.1016/j.eururo.2012.02.054
- Clarke NW1, Hart CA, Brown MD (2009). Molecular mechanisms of metastasis in prostate cancer. Asian J Andro, 11, 57-67. https://doi.org/10.1038/aja.2008.29
- Clarke WN, Brown DM (2007). The Influence of Lipid Metabolism on Prostate Cancer Development and Progression: Is it Time for a Closer Look? Euro Urol, 52, 3-4. https://doi.org/10.1016/j.eururo.2007.04.039
-
Dandona P, Weinstock R, Thus k, et al (1998). Tumor necrosis factor -
$\alpha$ , in sera of obese patients fall with weight loss. J Clin Endocrinol Metab, 83, 2907-10. - Garfinkel L (1986). Overweight and mortality. Cancer, 58, 1826-29. https://doi.org/10.1002/1097-0142(19861015)58:8+<1826::AID-CNCR2820581407>3.0.CO;2-6
- Gillitzer R, Pahernik S, Hampelc (2005). Relationship between prostate cancer and serum dyslipidemia. Urology, 66, 13-14.
- Giovannucci E, Stampfer MJ, Krithivas K, et al (1997). The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A, 94, 3320-23. https://doi.org/10.1073/pnas.94.7.3320
- Girling JF, Whitaker HC, Mills IG (2007). Pathogenesis of prostate cancer and hormone refractory prostate cancer. Indian J Urol, 23, 35-42. https://doi.org/10.4103/0970-1591.30265
- Gupta A, Gupta S, Pavuk M, Roehrborn CG (2006). Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology, 68, 1198-205. https://doi.org/10.1016/j.urology.2006.09.034
- Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D (1998). Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis, 3, 157-62.
- Hsing AW, Sakoda LC, Chua SC (2007). Obesity, metabolic syndrome, and prostate cancer. Amer J Clin Nutr, 86, 843-57.
- Jaradeen, N (2010). Breast cancer risk-factors and breast self examination practice among Jordanian women. Bahrain Med Bulletin, 32, 1
- Lekili M, Muezzinoglu T, Uyanik BS, Buyuksu C (2006). Serum lipid levels in benign prostatic hyperplasia. World J Urol, 24, 210-3. https://doi.org/10.1007/s00345-006-0062-6
- Long XJ, Lin S, Sun YN, Zheng ZF (2012). Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev, 13, 4097-100. https://doi.org/10.7314/APJCP.2012.13.8.4097
- McGrowder DA, Jackson LA, Crawford TV (2012). Prostate cancer and metabolic syndrome: is there a link? Asian Pac J Cancer Prev, 13, 1-13. https://doi.org/10.7314/APJCP.2012.13.1.001
- Mitropoulos D, Ploumidou K, Voulgari K (2003) Hypercholesterol diet alters serum lipid profile and ventral prostate structure in rats. Eur Urol Suppl, 63, 2-20.
- Nandeesha H, Koner BC, Dorairajan LN, Sen SK (2006). Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clinica Chimica Acta, 370, 89-93. https://doi.org/10.1016/j.cca.2006.01.019
- Nomura AM, Kolonel LN (1991). Prostate cancer: a current perspective. Epidemiol Rev, 13, 200-27.
- Ozbek E, Otunctemur A, Dursun M, et al (2014). The metabolic syndrome is associated with more aggressive prostate cancer. Asian Pac J Cancer Prev, 15, 4029-32. https://doi.org/10.7314/APJCP.2014.15.9.4029
- Pandeya DR, Mittal A, Sathian B, Bhatta B (2014). Role of hyperinsulinemia in increased risk of prostate cancer: a case control study from Kathmandu Valley. Asian Pac J Cancer Prev, 15, 1031-3. https://doi.org/10.7314/APJCP.2014.15.2.1031
- Parsons JK, Bergstrom J, Barrett CE (2008). Lipids, Lipoproteins and Risk of benign prostatic hyperplasia in communitydwelling Men. BJU Int, 101, 313-8. https://doi.org/10.1111/j.1464-410X.2007.07332.x
- Platz EA, Leitzmann MF, Visvanathan K, et al (2006). Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst, 98, 1819-25. https://doi.org/10.1093/jnci/djj499
- Prabhat P, Tewari R, Natu SM, et al (2010). Is central obesity, hyperinsulinemia, and dyslipidemia associated with highgrade prostate cancer? A descriptive cross-sectional study. Ind J Uro, 26, 502-6. https://doi.org/10.4103/0970-1591.74440
- Stephen JF, Brady JB (2005). Obesity and prostate cancer: a growing problem. Clin Cancer Res, 11, 6763-6. https://doi.org/10.1158/1078-0432.CCR-05-1305
- Tewari R, Prabhat P, Natu SM, et al (2011). Association of benign prostatic hyperplasia (BPH) with metabolic syndrome (MS) and its components: A growing dilemma. J Men's Health, 8, 66-71. https://doi.org/10.1016/j.jomh.2010.09.231
- Tewari R, Rajender S, Natu SM, et al (2012). Diet, obesity, and prostate health: are we missing the link? J Andro, 33, 763-76 https://doi.org/10.2164/jandrol.111.015578
- Tewari R, Rajender S, Natu SM, et al (2013). Significance of obesity markers and adipocytokines in high grade and high stage prostate cancer in North Indian men - a cross-sectional study. Cytokine, 10, 130-4.
- Wuermli L, Joerger M, Henz S, et al (2005). Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis, 8, 316-20. https://doi.org/10.1038/sj.pcan.4500834
- Zeigler-Johnson CM, Walker AH, Mancke B et al (2002). Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum Hered, 54, 13-21. https://doi.org/10.1159/000066695
- Zhang Q, Sun LJ, Qi J, Yang ZG, Huang T (2014). Influence of adipocytokines and periprostatic adiposity measurement parameters on prostate cancer aggressiveness. Asian Pac J Cancer Prev, 15, 1879-83. https://doi.org/10.7314/APJCP.2014.15.4.1879
- Zucchetto A, Tavani A, Dal ML, et al (2005). A history of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obes, 29, 798-803. https://doi.org/10.1038/sj.ijo.0802979
피인용 문헌
- Investigating the Incidence of Prostate Cancer in Iran 2005-2008 using Bayesian Spatial Ecological Regression Models vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5917
- Conditional PTEN-deficient Mice as a Prostate Cancer Chemoprevention Model vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1827
- Rising Cancer Incidence and Role of the Evolving Diet in Kenya pp.1532-7914, 2019, https://doi.org/10.1080/01635581.2018.1542010